Discovery of JNJ-87562761, a novel anti-GPRC5D enhanced effector function (eEF) antibody with multiple mechanisms of action for the treatment of multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Bradley Heidrich, Xiefan Lin-Schmidt, James Testa Jr., Heather Harlin, Jessica Raad, Alexa Marthaler, Katrin Sproesser, Bethany Mattson Cypert, Nicholas Hein, Adam Zwolak, Kavita Raman, William Rittase, Tatiana Perova, Sangmin Lee, Amber D'Souza, M. Phillip DeYoung, Wan Cheung Cheung, Jordan Schecter, Ulrike Philippar
Institution: Johnson & Johnson (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417006202
Cites:
Cited by:
Related to: